Odesivimab |
Catalog No.GC72434 |
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2135632-30-1
Sample solution is provided at 25 µL, 10mM.
Odesivimab (REGN-3471) neutralizes pseudovirus particles in vitro. Odesivimab with Atoltivimab and Maftivimab has an IC50 value of 0.39 nM[1].
Odesivimab with Atoltivimab and Maftivimab (REGN-3471; 50 mg/kg) has protective effect in the rhesus macaque model of Ebola virus infection[1].
References:
[1]. Markham A. REGN-EB3: First Approval. Drugs. 2021 Jan;81(1):175-178.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *